InnoCare Pharma Statistics

Total Valuation

InnoCare Pharma has a market cap or net worth of HKD 28.40 billion. The enterprise value is 22.10 billion.

Market Cap	28.40B
Enterprise Value	22.10B

Important Dates

The last earnings date was Friday, April 24, 2026.

Earnings Date	Apr 24, 2026
Ex-Dividend Date	n/a

Share Statistics

InnoCare Pharma has 1.70 billion shares outstanding. The number of shares has decreased by -0.97% in one year.

Current Share Class	1.43B
Shares Outstanding	1.70B
Shares Change (YoY)	-0.97%
Shares Change (QoQ)	-8.70%
Owned by Insiders (%)	20.72%
Owned by Institutions (%)	30.25%
Float	1.13B

Valuation Ratios

The trailing PE ratio is 28.48 and the forward PE ratio is 97.30.

PE Ratio	28.48
Forward PE	97.30
PS Ratio	9.91
PB Ratio	3.39
P/TBV Ratio	3.52
P/FCF Ratio	n/a
P/OCF Ratio	790.77
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 29.58, with an EV/FCF ratio of -446.61.

EV / Earnings	26.63
EV / Sales	7.71
EV / EBITDA	29.58
EV / EBIT	35.54
EV / FCF	-446.61

Financial Position

The company has a current ratio of 5.65, with a Debt / Equity ratio of 0.21.

Current Ratio	5.65
Quick Ratio	5.23
Debt / Equity	0.21
Debt / EBITDA	2.33
Debt / FCF	-35.19
Interest Coverage	10.11

Financial Efficiency

Return on equity (ROE) is 10.36% and return on invested capital (ROIC) is 26.31%.

Return on Equity (ROE)	10.36%
Return on Assets (ROA)	3.45%
Return on Invested Capital (ROIC)	26.31%
Return on Capital Employed (ROCE)	6.13%
Weighted Average Cost of Capital (WACC)	6.36%
Revenue Per Employee	2.44M
Profits Per Employee	705,891
Employee Count	1,176
Asset Turnover	0.25
Inventory Turnover	1.61

Taxes

In the past 12 months, InnoCare Pharma has paid 13.69 million in taxes.

Income Tax	13.69M
Effective Tax Rate	1.62%

Stock Price Statistics

The stock price has increased by +41.15% in the last 52 weeks. The beta is 0.42, so InnoCare Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.42
52-Week Price Change	+41.15%
50-Day Moving Average	13.18
200-Day Moving Average	14.82
Relative Strength Index (RSI)	46.03
Average Volume (20 Days)	10,541,699

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, InnoCare Pharma had revenue of HKD 2.87 billion and earned 830.13 million in profits. Earnings per share was 0.49.

Revenue	2.87B
Gross Profit	2.62B
Operating Income	621.95M
Pretax Income	845.90M
Net Income	830.13M
EBITDA	713.37M
EBIT	621.95M
Earnings Per Share (EPS)	0.49

Full Income Statement

Balance Sheet

The company has 8.06 billion in cash and 1.74 billion in debt, giving a net cash position of 6.32 billion or 3.73 per share.

Cash & Cash Equivalents	8.06B
Total Debt	1.74B
Net Cash	6.32B
Net Cash Per Share	3.73
Equity (Book Value)	8.37B
Book Value Per Share	4.73
Working Capital	7.67B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 35.92 million and capital expenditures -85.41 million, giving a free cash flow of -49.49 million.

Operating Cash Flow	35.92M
Capital Expenditures	-85.41M
Depreciation & Amortization	92.17M
Net Borrowing	259.13M
Free Cash Flow	-49.49M
FCF Per Share	-0.03

Full Cash Flow Statement

Margins

Gross margin is 91.36%, with operating and profit margins of 21.69% and 28.95%.

Gross Margin	91.36%
Operating Margin	21.69%
Pretax Margin	29.51%
Profit Margin	28.95%
EBITDA Margin	24.88%
EBIT Margin	21.69%
FCF Margin	n/a

Dividends & Yields

InnoCare Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	4.61%
Buyback Yield	0.97%
Shareholder Yield	0.97%
Earnings Yield	2.92%
FCF Yield	-0.17%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6